Golden Retriever Lifetime Study
Morris Animal Foundation's Golden Retriever Lifetime Study will help identify major nutritional, genetic and environmental risk factors for cancer and other important diseases in dogs.
Evaluating a Novel Adjunct Treatment for Hemangiosarcoma
Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.
Improving Management of Lymphocytic Leukemia
Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.
Improving Diagnosis and Treatment of a Severe Bleeding Disorder
Researchers will develop an assay to measure canine thrombopoietin (TPO), a bone marrow growth factor, to improve the diagnosis and treatment of bleeding disorders in dogs with immune platelet defects.
Improving Blood Platelet Transfusions
Researchers will evaluate the effects of additive solutions to improve blood platelet efficacy and storage for life-saving transfusion in dogs.
Using Advanced Imaging to Diagnose and Monitor Spinal Cord Disease
Researchers will evaluate an advanced imaging technique to improve the diagnosis and monitoring of spinal cord lesions associated with canine degenerative myelopathy, a spinal cord disease in dogs.